Search

Your search keyword '"(0000-0001-5286-4319) Pietzsch, H.-J."' showing total 56 results

Search Constraints

Start Over You searched for: Author "(0000-0001-5286-4319) Pietzsch, H.-J." Remove constraint Author: "(0000-0001-5286-4319) Pietzsch, H.-J."
56 results on '"(0000-0001-5286-4319) Pietzsch, H.-J."'

Search Results

1. Towards the Stable Binding of Mercury: Synthesis and Functionalization of Dibenzyldiazabicyclononane Scaffolds

2. Entwicklung alternativer Verbindungen für die PSMA-Therapie mit Actinium-225

Catalog

Books, media, physical & digital resources

3. Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-133

4. Radiotheranostika gegen Prostatakrebs: Actinium-225-Radiokonjugate für eine verbesserte Therapie

5. Assessing the binding affinity of a 64Cu-labeled PSMA ligand in a micro physiological system

6. Calix[4]crowns with perfluoroalkylsulfonylcarboxamide functions: a complexation approach for heavy group 2 metal ions

7. Enzymological characterization of ⁶⁴Cu-labeled neprilysin substrates and their application for modulating the renal clearance of targeted radiopharmaceuticals

8. Enzymological characterization of ⁶⁴Cu-labeled neprilysin substrates and their application for modulating the renal clearance of targeted radiopharmaceuticals

9. Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives

10. Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5

11. Calix[4]crowns with perfluoroalkylsulfonylcarboxamide functions: a complexation approach for heavy group 2 metal ions

12. Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-133

13. Entwicklung alternativer Verbindungen für die PSMA-Therapie mit Actinium-225

14. Radiotheranostika gegen Prostatakrebs: Actinium-225-Radiokonjugate für eine verbesserte Therapie

15. Synthese und Radiomarkierung von macropa-PSMA-Derivaten für die Tumorbildgebung mit Iod-123

16. Entwicklung alternativer Verbindungen für die PSMA-Therapie mit Actinium-225

17. Copper-free click bioconjugation of technetium-99m complexes using strained cyclononyne derivatives

18. Influence of Albumin Binders on Tumor Uptake of 225Ac-mcp-PSMA-Radioconjugates

19. Copper-free Click Labeling with the 99mTc-Tricarbonyl-Core Using DACN Derivatives

20. Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates

21. Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer

22. Synthesis and preclinical evaluation of rhenium and technetium-99m “4 + 1” mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents

23. Introducing micro physiological systems to evaluate new radiopharmaceuticals: First attempts with radiolabeled cetuximab

24. Efficient Production of the PET radionuclide 133La for Theranostic Purposes in Targeted Alpha Therapy using the 134Ba(p,2n)133La Reaction

25. Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer

26. Influence of Albumin Binders on Tumor Uptake of 225Ac-mcp-PSMA-Radioconjugates

27. Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates

28. Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer

29. Enhanced blood retention and tumor uptake of PSMA-targeting, 225Ac-labeled radioconjugates

30. 131Ba as a promising SPECT-diagnostic match for 223/224Radium

31. Towards Targeted Alpha Therapy with Actinium 225: Chelators for Mild Condition Radiolabeling and Targeting PSMA – a Proof of Concept Study

32. Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial

33. Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics

34. 131Ba as a promising SPECT-diagnostic match for 223/224Radium

35. 131Ba as a promising SPECT-diagnostic match for 223/224Radium

36. Barium-131 as starting point for the development of radiotheranostic approaches

37. Barium-131 as starting point for the development of radiotheranostic approaches

38. Recent insights in barium-131 as a diagnostic match for radium-223: cyclotron production, separation, labeling and imaging

39. Radiopharmaceutical Sciences

40. P1826 - Calix[n]aren-Derivate zur Komplexierung von Erdalkalimetallkationen

41. Kit-like 18F-labeling using triazole-linked conjugates for [18F]aluminum monofluoride complexation

42. Introduction of the New Center for Radiopharmaceutical Cancer Research at Helmholtz-Zentrum Dresden-Rossendorf

43. Facile preparation of radium-doped, functionalized nanoparticles as carriers for targeted alpha therapy

44. Facile preparation of radium-doped, functionalized nanoparticles as carriers for targeted alpha therapy

45. Kit-like 18F-labeling using triazole-linked conjugates for [18F]aluminum monofluoride complexation

46. P1802 - Universal Building Blocks for Radiolabeling

47. Radiumdotierte Bariumsulfat-Nanopartikel für die zukünftige Alphatherapie

48. Radiopharmacological Evaluation of Cyclohexanediamine-Triazole-Peptide Conjugates Labeled via the Al18F-Approach

49. Sulfonated calix-baskets for complexation of Barium and Radium

50. Radiumdotierte Bariumsulfat-Nanopartikel für die radiotherapeutische Anwendung